Your Rheumatologist's Diagnosis of MCTD is Correct, and Your Prognosis is Good
Based on your markedly elevated anti-RNP antibodies (86, normal <20), speckled ANA pattern at 1:160, proximal muscle weakness, and modestly elevated CK, you have Mixed Connective Tissue Disease (MCTD) with myositis features—this is NOT a death sentence, and with appropriate treatment, most patients achieve good functional outcomes and normal life expectancy.
Understanding Your Diagnosis
Your clinical picture strongly supports MCTD:
- High anti-RNP antibodies are the hallmark of MCTD—your level of 86 (and earlier 4.7) with negative anti-Smith, anti-dsDNA, and anti-Jo-1 antibodies is classic for this condition
- Proximal muscle weakness (shoulders, hips, thighs) with modestly elevated CK (371-527) indicates inflammatory myopathy as part of your MCTD
- Speckled ANA pattern at 1:160 titer fits the serologic profile
- Normal AST/ALT (24) despite elevated CK suggests muscle-specific inflammation rather than liver involvement
- Improving symptoms (no longer struggling to get up from couch/bed) suggest you may be in a fluctuating or early phase
What Your EMG Will Likely Show
Your EMG tomorrow will likely demonstrate myopathic changes 1:
- Polyphasic motor unit action potentials of short duration and low amplitude
- Increased insertional activity with fibrillation potentials, sharp waves, or repetitive discharges
- These findings confirm a myopathic (muscle inflammation) process rather than neurogenic (nerve) disease
The EMG serves two purposes: (1) confirming inflammatory myopathy, and (2) identifying the best muscle for biopsy if needed 1.
Do You Need a Muscle Biopsy?
You may not need a muscle biopsy immediately 2, 1. According to the 2017 EULAR/ACR classification criteria, diagnosis can be made with or without muscle biopsy 2. Your case has:
- Age 30 years (score: 1.3-1.5 points)
- Proximal upper and lower extremity weakness (score: 0.7 + 0.8 points)
- Elevated CK (score: 1.3-1.4 points)
- Positive anti-RNP (though not anti-Jo-1, which would score 3.9 points)
A muscle biopsy becomes necessary if:
- Your EMG is inconclusive or normal
- You don't respond to initial immunosuppressive therapy
- There's diagnostic uncertainty between inflammatory myopathy and muscular dystrophy 1
The biopsy would show endomysial or perimysial mononuclear cell infiltration if inflammatory myopathy is present 2.
Your Cardiac Workup is Appropriate and Important
Your upcoming heart monitor and stress test on Friday are essential because:
- MCTD can involve cardiac complications (though less common than in other inflammatory myopathies)
- Your mildly elevated troponin (9→6 ng/L) needs evaluation, though it normalized
- Normal chest X-rays and 12-lead EKG are reassuring
- CK elevation can sometimes reflect cardiac muscle involvement
The cardiac monitoring is precautionary—your normal troponin trend and normal EKGs suggest no acute cardiac injury.
Your G6PD Deficiency: A Complicating Factor
Your G6PD deficiency (41, normal 100-400) is significantly low and may contribute to your clinical picture 3, 4:
- G6PD deficiency can rarely cause rhabdomyolysis (severe muscle breakdown) even without hemolysis 3
- Your elevated CK could partially reflect G6PD-related muscle injury superimposed on MCTD myositis
- Critical: Avoid oxidative stressors (certain medications, fava beans, infections) that can trigger hemolysis or worsen muscle symptoms 3, 4
This is NOT causing your primary disease but may amplify muscle symptoms.
Your Medications: Important Considerations
Amlodipine (your blood pressure medication):
- Rarely, calcium channel blockers like amlodipine can cause myalgias, arthralgias, and muscle weakness 5
- However, your symptoms preceded or coincided with MCTD diagnosis, making amlodipine an unlikely primary cause
- Continue it for blood pressure control unless your rheumatologist advises otherwise 6
GLP-1 agonist (for weight loss):
- Generally safe and may even help with blood pressure control 7
- No known association with myopathy
- Continue as prescribed
Will You Survive This? Absolutely Yes.
MCTD has a favorable prognosis compared to other connective tissue diseases:
- Most patients respond well to immunosuppressive therapy
- Life expectancy is near-normal with appropriate treatment
- Your improving symptoms (no longer weak getting up from couch/bed) suggest you're already responding, possibly to physical therapy or natural disease fluctuation
- Serious complications (pulmonary hypertension, severe organ involvement) are uncommon and typically develop over years, not acutely
Your specific favorable factors:
- Young age (30 years)
- Early diagnosis and treatment
- Normal renal function (creatinine stable, eGFR 87-93)
- No pulmonary involvement (normal chest X-ray, no fluid)
- Improving muscle strength
- Active engagement in physical therapy and mental health support
Expected Treatment Plan
Your rheumatologist will likely recommend:
- Corticosteroids (prednisone 0.5-1 mg/kg/day initially) as first-line therapy for MCTD with myositis
- Steroid-sparing immunosuppressants (methotrexate, azathioprine, or mycophenolate) added early to minimize steroid exposure
- Avoid medications that trigger hemolysis given your G6PD deficiency (certain antibiotics, antimalarials like hydroxychloroquine may need caution)
- Continue physical therapy to maintain muscle strength and prevent contractures
- Regular monitoring of CK, muscle strength, and organ involvement
Common Pitfalls to Avoid
- Don't stop treatment prematurely when symptoms improve—MCTD requires sustained immunosuppression
- Avoid oxidative stressors (infections, certain drugs) that could trigger G6PD-related complications
- Monitor for steroid side effects (weight gain, diabetes, bone loss)—your obesity and hypertension increase these risks
- Don't ignore new symptoms (shortness of breath, Raynaud's phenomenon, joint swelling) that may indicate disease progression
Bottom Line
You have MCTD with inflammatory myopathy, confirmed by high anti-RNP antibodies, proximal muscle weakness, and elevated CK. This is a treatable condition with excellent prognosis when managed appropriately. Your improving symptoms are encouraging. The EMG will confirm myopathy, and a muscle biopsy may be deferred if the EMG is diagnostic. Your G6PD deficiency requires medication vigilance but doesn't change your overall good prognosis. You will survive this—MCTD is a chronic but manageable condition, not a death sentence 2, 1.